NSEPress Release2 Nov 2026 · 2 Nov 2026, 08:09 am

Press Release

Hikal Limited · HIKAL

✦ AI Summary▲ PositiveOrder Win

Hikal Limited has signed a multi-year contract with a Europe-based global agrochemical company to supply a specialized agrochemical product to markets worldwide. The contract covers contract development and manufacturing (CDMO) of the product, with commercial launch expected towards the end of FY 2026–27.

Analysis Scores

Earnings Impact8/10
Growth Catalyst9/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk5/10
Liquidity Impact9/10
Market Sentiment8/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Hikal Limited has informed the Exchange regarding a press release dated November 02, 2026, titled "Press Release- Hikal limited signs Multi- year Global CDMO contract with leading Agrochemical Company".

Attachments (1)

📄

HIKAL_02112026080916_SEIntNov022026.pdf

pdf

Download →
View document text
November 02, 2026 BSE Limited, National Stock Exchange of India Limited, P J Towers, Exchange Plaza, Dalal Street, Bandra-Kurla Complex, Bandra, Mumbai - 400 001. Mumbai - 400 051. Scrip Code: 524735 Symbol: HIKAL Dear Sir/Madam, Subject: Press Release- Hikal Signs Multi-Year Global CDMO Contract with Leading Agrochemical Company Please find enclosed herewith, a copy of the press release titled “Hikal Signs Multi-Year Global CDMO Contract with Leading Agrochemical Company”. This is for your information and records. Thank you, Yours Sincerely, For Hikal Limited, Rajasekhar Reddy Company Secretary & Compliance Officer Encl: As above Hikal Ltd. Admin. Office: Great Eastern Chambers, 6th Floor, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India. Tel. + 91–22–6277 0299, + 91–22–6866 0300 Regd. Office: 717/718, Maker Chambers - 5, Nariman Point, Mumbai - 400 021, India. Tel. +91-22 6277 0477. Fax: + 91-22 6277 0500 www.hikal.com info@hikal.com CIN: L24200MH1988PTC048028 Hikal Signs Multi-Year Global CDMO Contract with Leading Agrochemical Company Contract follows successful Process Development and scale-up of a new product, marking a key commercial milestone for Hikal’s Crop Protection business Mumbai, November 2, 2026: Hikal Limited (BSE: 524735 | NSE: HIKAL) has signed a multi-year contract with a Europe-based global agrochemical company to supply a specialised agrochemical product to markets worldwide. The contract, signed by Hikal’s Crop Protection division, covers contract development and manufacturing (CDMO) of the product for which Hikal undertook process development and scale-up. Commercial launch is expected towards the end of FY 2026–27, with volumes anticipated to grow progressively as regulatory approvals are secured across global markets. The partnership underscores Hikal’s capabilities in process development and commercialisation, demonstrating its ability to translate customer requirements into long-term manufacturing opportunities. It also strengthens Hikal’s Crop Protection business by expanding its portfolio of specialised offerings for global customers. Commenting on the development, Mr. Sameer Hiremath, Chairman & Managing Director, Hikal Limited, said: “This contract marks an important milestone for our Crop Protection business, converting nearly three years of collaborative development and scale-up into a long-term commercial partnership. It demonstrates Hikal’s ability to combine deep technical expertise with reliable manufacturing capabilities to take complex products from development to commercial supply. We are well positioned to support the planned launch and progressive expansion of supplies across global markets. Hikal partners with global companies across pharmaceuticals, crop protection, animal health and specialty chemicals, leveraging its research and development, process chemistry and manufacturing capabilities to support customers from development through commercial production. About Hikal Limited Established in 1988, Hikal is a reliable partner to companies in the Pharmaceutical, Animal Health, Biotech, Personal Care and Specialty Chemical industries. We manufacture and supply quality Active Ingredients, Intermediates, Biocides to the global life sciences industry. Hikal has five manufacturing facilities in India at Maharashtra (Taloja and Mahad), Gujarat (Panoli) and Bengaluru (Jigani) and a world-class Research & Technology centre at Pune. Our facilities have been inspected and certified by the Global Regulatory Authorities. We create and deliver sustainable solutions for our partners and customers across the life-sciences value chain. Hikal believes in inclusive growth that embraces all constituents. Hikal is one of the first Indian life-sciences companies to receive the Responsible Care® certification and has also been awarded the EcoVadis Gold Medal rating, placing it among the top 5% of companies assessed globally for sustainability performance. We accord top priority to the health and safety of our employees by adopting best practices in manufacturing.